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E-mail address: moosmann@uni-mainz.de (B. MooTocopherol is believed to be the most potent naturally occurring chain-breaking antioxidant. Hence,
its reﬁned phenolic head group chromanol may represent an optimum evolutionary solution to the
problem of free-radical chain reactions in the lipid bilayer. To test the universal validity of this
assumption beyond phenolic head groups, we have synthesized aromatic amine analogues of vita-
min E and trolox with otherwise closely matching physicochemical properties: NH-toc and NH-trox.
We have found that NH-toc and NH-trox were signiﬁcantly more potent free radical scavengers, lipid
peroxidation inhibitors and cytoprotective agents than their phenolic templates, tocopherol and
trolox. In a chemical sense, thus, the chromanol head group does not constitute a global optimum
for the design of chain-breaking antioxidants.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Tocopherols and tocotrienols (vitamin E) are among the most
potent chain-breaking antioxidants known [1], and they play a
central role for the functionality of a variety of cells and tissues,
such as cerebellar, peripheral, and retinal neurons [2,3]. Tocopherol
is also the most effective natural antioxidant to protect cultivated
neuronal cells from oxidative cell death [4,5]. Hence, tocopherol
can translate its high in vitro activity into the in vivo situation,
whereas many other radical scavengers partially or fully lose their
apparent in vitro activity when tested in intact cells, for example
spin traps [4–7].
It has been hypothesized that tocopherol’s chromanol head
group may reﬂect an optimum evolutionary answer to the threat
of toxic free-radical chain reactions in the lipid bilayer. This con-
clusion has primarily been drawn from favourable comparisons
with other phenols in vitro, in vivo and in silico [1,4,5,8–12]. Even
sophisticated approaches to the optimization of the chromanol
head group [12,13] and elaborate de novo strategies [14,15] have
yielded only modestly more potent structures. Moreover, the re-
ported higher reactivities of certain dihydrobenzofuranols [12] or
pyridinols [14] towards peroxyl radicals were achieved by com-chemical Societies. Published by E
thobiochemistry, University
sity, Duesbergweg 6, 55099
smann).pounds with a signiﬁcantly smaller molecular weight and a corre-
spondingly higher diffusion coefﬁcient than tocopherol, suggesting
that this factor may have been a primary cause of the observed
improvement. This possibility is relevant as smaller compounds
will generally not achieve the same favourable distribution and
retention in cells and tissues as tocopherol does [16], potentially
nullifying the compiled in vitro advantage. Apparently, in no case
has a compound of the same, relatively high molecular weight as
tocopherol been reported to be more potent than the latter in
terms of its EC50 value in a biologically relevant peroxidation assay.
In consequence of tocopherol’s unsurpassed efﬁcacy in many
experimental settings, its chromanol head group has frequently
been favoured as template for the development of intentionally
smaller (and thus more diffusible), more hydrophilic (and thus
not membrane-restricted), or otherwise tailored artiﬁcial antioxi-
dant substances [12,13,17,18]. Speciﬁcally, the amphiphilic, car-
boxylated chromanol compound trolox [17] has become a widely
employed standard for the assessment of free radical scavenging
activities in terms of the ‘‘trolox equivalent antioxidant capacity’’
(TEAC) assay [19].
In an effort to expand the chemical space of hydrogen radical-
donating antioxidants, we have investigated whether the substitu-
tion of oxygen in phenolic compounds by nitrogen might be asso-
ciated with an improved stability of transiently formed antioxidant
radicals, especially as amines offer the potential to add two aro-
matic rings to the primary site of radicalization (Fig. 1A). Aromatic
amines, especially secondary amines with bridged aromaticlsevier B.V. All rights reserved.
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Fig. 1. Chemical structures. (A) The chemical structures of phenol and diphenylamine, illustrating that amines can form bonds to two independent aromatic systems while
retaining a homolytically dissociable NH bond. (B) The chemical structures of a-tocopherol, trolox, NH-toc, and NH-trox. Boxes indicate the pairwise identical solubility-
determining side-chains; the remainder of each molecule was deﬁned as its head group. Asterisks label the atoms that were chosen for molecular distance calculations.
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sess a very versatile redox biochemistry [21], and similarly as
tocopherol, they can translate their antioxidant activity in vitro
into the in vivo situation [22]. For example, aromatic amines have
recently been shown to afford complete and receptor-independent
antioxidant protection against dopaminergic neurodegeneration in
Caenorhabditis elegans nematodes treated with the prooxidative
complex I inhibitors rotenone and MPP+ [23]. In the following,
we thus report on the synthesis of two novel, amine-based head
group analogues of trolox and tocopherol, and we evaluate their
antioxidant potential.
2. Materials and methods
2.1. Chemicals
All chemicals and biochemicals were from Sigma–Aldrich if not
otherwise indicated. Cell culture reagents were from Invitrogen. 2-
Cyano-phenothiazine was obtained from Bernhagen-Chemie; phy-
tanic acid was from Cayman Chemicals. Synthetic (±)-a-tocopherol
(purity 97%) and natural (+)-c-tocopherol (purity 99%) were from
Sigma–Aldrich.
2.2. Synthesis and computational evaluation of NH-toc and NH-trox
The synthesis of NH-toc (Fig. 1) was achieved by reduction of 2-
cyano-phenothiazine to 2-aminomethyl-phenothiazine with
LiAlH4 in dichloromethane at RT, following a standard protocol
[24]. The resulting primary amine was then coupled with phytanic
acid using ethylchloroformate/N,N-diisopropylethylamine in
20 C DMF essentially as published [25]. The compound NH-trox
(Fig. 1) was synthesized from 2-cyano-phenothiazine by hydrolysis
in reﬂuxing concentrated HCl/acetic acid according to customary
protocols [26]. All compounds were puriﬁed by precipitation and
re crystallization, or by preparative column chromatography. Their
identity and purity were veriﬁed by 1H NMR spectroscopy, mass
spectrometry, and analytical thin-layer chromatography.
Molecular calculations yielding logP values and molecular dis-
tances were performed with the ChemDraw/Chem3D software
package (CambridgeSoft). Semi-empirical quantum chemical cal-
culations to determine heats of formation, orbital energies anddipolar moments were accomplished with the implemented
Chem3D MOPAC routine, using the AM1 Hamiltonian as described
[20].
2.3. Assessment of the antioxidant activity of NH-toc and NH-trox
The in vitro ability of the investigated compounds to react with
free radicals was determined by measuring their quenching of pre-
formed 2,20-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid)
(ABTS) radicals in aqueous and ethanolic solution. The results were
expressed as trolox equivalent antioxidant capacities (TEACs) as
described [27].
The biochemical activity of NH-toc and NH-trox to prevent lipid
peroxidation was investigated in a native preparation of highly
unsaturated rat brain membranes [10]. Lipid peroxidation was in-
duced by treatment with iron/ascorbate or iron/H2O2 and was
quantiﬁed by measuring (i) end products of polyunsaturated fatty
acid degradation (thiobarbituric acid-reactive substances, TBARS)
and (ii) the speciﬁc formation of 8-iso prostaglandin F2a (8-iso-
prostane) from arachidonic acid. TBARS were measured exactly
as described [22], 8-isoprostanes were analyzed by enzyme immu-
noassay (Cayman Chemicals).
The protection of cultivated murine clonal hippocampal neu-
rons (HT22 cells) from oxidative glutamate toxicity [28] was em-
ployed to assess the in vivo antioxidant activity of the
compounds under investigation. Cell cultivation and propagation
as well as the analysis of cell survival and cell viability were done
as detailed [20]. Two independent methods to assess cellular sur-
vival and viability were employed, (i) the metabolic reduction of
the 3-(4,5-dimethylthiazol-2-yl-)-2,5-diphenyltetrazolium (MTT)
cation towards a coloured formazan, which is exclusively afforded
by viable cells, and (ii) the exclusion of the ﬂuorescent DNA-inter-
calating dye propidium iodide (PI) from cells with intact plasma
membrane. Quantiﬁcation was achieved by photometric analysis
(MTT test) and by visual inspection and counting of intact and
damaged cells under the microscope (PI test).
2.4. Cellular incorporation of NH-toc and NH-trox
An HPLC routine was employed to monitor the relative cellular
incorporation of the novel compounds. HT22 cells treated with the
M.J. Ohlow et al. / FEBS Letters 586 (2012) 711–716 713compounds under investigation were cultivated as in the cytopro-
tection experiments. At the indicated time, the medium was re-
moved, and the cells were harvested mechanically in a fresh
aliquot of cultivation medium. For the analysis of tocopherol and
NH-toc, the samples were vigorously extracted with 4 vol of meth-
anol at 4 C, followed by centrifugation at 7500g for 20 min. The
upper, clear phase was directly injected onto a C18 reversed-phase
column and eluted with methanol:water (96:4, v/v). Tocopherol
was detected by its ﬂuorescence at 296/340 nm, NH-toc was traced
via its absorption at 254 nm. For the analysis of trolox and NH-trox,
the aqueous phases were acidiﬁed with 0.05 vol of 6 M HCl before
extraction with 3 vol of ether. The ether phase was vacuum dried,
and the residue was dissolved in a small volume of methanol.
Immediately before injection onto a C18 reversed-phase column,
the methanolic solution was mixed 1:1 (v/v) with mobile phase,
consisting of methanol:water:acetonitrile:acetic acid (47:47:5:1,
v/v/v/v) adjusted to 20 mM phosphoric acid. Trolox was quantiﬁed
at 292 nm excitation/327 nm emission, NH-trox was monitored at
254 nm.3. Results
3.1. Design and computational characterization of NH-toc and NH-
trox
In order to assess in how far the chromanol head group of
tocopherol was functionally optimized, we have attempted to de-
sign and synthesize head group analogues of tocopherol (and trol-
ox) with as little difference as possible to the corresponding
parental structures regarding the relevant size and solubility
parameters, yet with as much difference as possible regarding
the electronic nature and radicalization behaviour of the newly
introduced hydrogen-donating head group. The synthesized con-
sensus structures are shown in Fig. 1B, with their calculated size,
solubility and electronic characteristics listed in Table 1.
NH-toc was generated by coupling a hydrophobic phytyl tail to
a 2-aminomethyl-phenothiazine head group, to obtain a non-
saponiﬁable compound with similar size and geometry and very
similar hydrophobicity characteristics as tocopherol (Table 1).
NH-trox was generated by hydrolysis of 2-cyano-phenothiazine,
yielding a compound with essentially identical molecular weight
and octanol-water partition as trolox. In contrast, NH-toc and
NH-trox were characterized by signiﬁcantly lower radicalization
enthalpies (27 kcal/mol) than their already remarkable parental
structures (31.5 kcal/mol). Concomitantly, the electronic energy
levels of the lowest unoccupied molecular orbitals (LUMOs) of both
NH-radicals were markedly lower than in tocopherol and trolox
(by 1 eV corresponding to 23 kcal/mol) (Table 1). Both of these
energy differences would predict an increased propensity of the
NH-compounds to act as chain-breaking antioxidants [20].Table 1
Calculated chemical properties of a-tocopherol, NH-toc, trolox, and NH-trox.
Size Solubility
Mw a–x [Å] logP C lo
a-Tocopherol 430.72 21.22 9.98 12.0
NH-toc 522.83 24.80 9.72 11.8
Trolox 250.29 7.72 3.19 3.0
NH-trox 243.28 4.89 2.90 4.1
MW, molecular weight; a–x, molecular distance between the reactive heteroatom and th
are marked in Fig. 1); logP, octanol–water partition coefﬁcient calculated by an autonomo
non-autonomous fragmentation method; p(head), dipolar moment of the antioxidant hea
of each compound and its radicalized state (‘‘radicalization enthalpy’’); E(LUMOr), elec
orbital).3.2. Free radical scavenging activity of NH-toc and NH-trox
The potential of the newly designed compounds to directly
interact with preformed free radicals was evaluated by determin-
ing their trolox equivalent antioxidant capacities (TEACs). The re-
sults in Table 2 demonstrate that NH-trox was superior to trolox
both in aqueous and ethanolic medium. Similarly, NH-toc was
approximately twice as potent as a- or c-tocopherol in both sol-
vents. As expected, the lipophilic phytyl group-carrying com-
pounds were relatively disfavoured in the more polar, aqueous
medium. Notably, all tested compounds possess the same number
of scavenging groups, which is the factor that usually predomi-
nates in the experimental and theoretical explanation of differing
TEAC values [9,27]. Hence, the higher TEAC index of the NH-com-
pounds compared to their parental structures may indeed reﬂect
a higher antioxidant activity due to electronic factors.
3.3. Inhibition of lipid peroxidation by NH-toc and NH-trox
The TEAC assay is in general of rather poor predictive value
regarding the biologically relevant paradigms of oxidative stress
protection, such as the inhibition of lipid peroxidation, towards
which tocopherol has been optimized by evolution [1,29]. Hence,
the effect of NH-toc and NH-trox was investigated in a native prep-
aration of highly unsaturated rat brain membranes. It was found
that NH-toc was signiﬁcantly more effective in the inhibition of li-
pid peroxidation than a- or c-tocopherol, affording comparable
protection at 20- to 100-fold lower concentrations (Fig. 2). Com-
mensurate with this ﬁnding, NH-trox was approximately 20- to
100-fold more potent than trolox. The efﬁcacy advantage of the
NH-compounds was noted with two unrelated analytical methods,
i.e. the ﬂuorimetric quantiﬁcation of TBARS generation (Fig. 2A, B, E
and F), and the immunological analysis of 8-isoprostane formation
(Fig. 2C and D). Moreover, the advantage of the NH-compounds
was found to be equally pronounced with two different prooxidant
strategies, i.e. iron/ascorbate, which depends on endogenous, pre-
formed peroxides (Fig. 2A–D), and iron/H2O2, which does not
(Fig. 2E and F). These data indicate that the relative superiority of
NH-toc and NH-trox is unrelated to the presence or absence of re-
duced ascorbate, the most probable regenerator of tocopherol
in vivo.
3.4. Cytoprotective activity of NH-toc and NH-trox
To investigate whether the NH-compounds were able to trans-
late some of their biochemical lead into the situation in living cells,
cytoprotection assays in clonal hippocampal neurons were per-
formed, using cell death as readout for cellular antioxidant failure.
In this extended 24 h cell death assay (Fig. 3), all compounds pos-
sessing a lipophilic phytyl group, particularly a- and c-tocopherol,
were substantially more potent than in the cell-free lipidEnergy
gP p(head) [D] DHf [kcal/mol] E(LUMOr) [eV]
4 2.34 30.36 0.389
7 2.47 26.96 0.633
9 2.34 32.97 0.170
6 1.67 27.03 0.964
e solubility-determining side chain in a fully extended conformation (reading points
us fragmentation method; C logP, octanol–water partition coefﬁcient calculated by a
d group (boundaries are indicated in Fig. 1); DHf, difference in the heat of formation
tronic energy level of the radicalized state’s LUMO (lowest unoccupied molecular
Table 2
Trolox-equivalent antioxidant capacities (TEAC) of the investigated compounds in
two different solvents.
Aqueous Ethanolic
Trolox 1.00 ± 0 1.00 ± 0
NH-trox 1.73 ± 0.03 1.69 ± 0.11
a-Tocopherol 0.65 ± 0.04 0.80 ± 0.13
c-Tocopherol 0.74 ± 0.07 0.87 ± 0.02
NH-toc 1.30 ± 0.10 2.74 ± 0.42
Data are expressed as mean ± SD (n = 2, each determined from four different
concentrations).
714 M.J. Ohlow et al. / FEBS Letters 586 (2012) 711–716peroxidation assays (Fig. 2). Nevertheless, NH-toc remained to be
the most potent antioxidant with an EC50 value of 35 nM, as com-
pared to a-tocopherol with an EC50 value of 150 nM. Trolox and
NH-trox rather precisely retained their EC50 values from the iron/
ascorbate-induced lipid peroxidation assay, without any loss orA
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Fig. 2. Lipid peroxidation. (A) Activity of a-tocopherol, c-tocopherol, and NH-toc to preve
membranes (0.5 mg/ml protein) challenged with 10 lM Fe2+/200 lM ascorbate for 6 h. (
tocopherol, and NH-toc to prevent the formation of 8-isoprostane in rat brain membrane
Activity of a-tocopherol, c-tocopherol, and NH-toc to prevent TBARS generation in rat b
trolox and NH-trox in the same assay. All results are expressed as mean ± SD (n = 2).gain of activity in the cellular system. Hence, NH-trox remained
to be 50-fold more potent than trolox. The higher cytoprotective
activity of the NH-compounds was not caused by higher cellular
incorporation of these substances, as HPLC analyses indicated that
NH-toc and a-tocopherol, as well as NH-trox and trolox were pair-
wise identical in their potential to permeate cells (Fig. 3D). Thus, it
appears that the efﬁcacy advantage of the NH-compounds in neu-
ronal cells is indeed attributable to their improved structural abil-
ity to become stably radicalized and to so act as chain-breaking
antioxidants. Notably, the advantage of extreme lipophilicity as
conferred by a phytyl side chain seems to uncover only in cellular
investigations.
4. Discussion
In the present study, we demonstrate that it is possible, based
on the straightforward chemical calculation of only a few keyB
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Fig. 3. Cytoprotection. (A) Effect of a-tocopherol, c-tocopherol, and NH-toc on the viability (MTT reduction capacity) of HT22 cells challenged with 5 mM glutamate for 24 h.
(B) Activity of trolox and NH-trox under the same conditions. (C) Cytoprotective activity of trolox and NH-trox in glutamate-challenged HT22 cells as determined by the PI
exclusion test. (D) Cell penetration of a-tocopherol and NH-toc (10 lM), and of trolox and NH-trox (100 lM) after the indicated times of incubation. All results are expressed
as mean ± SD (A–C: n = 4; D: n = 2).
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cacy than tocopherol and trolox. This conclusion is drawn from a
number of assays that reﬂect the most relevant in vivo activity of
tocopherol, the interference with free-radical chain reactions in
non-polar environments. Given that tocopherol itself is a highly re-
ﬁned phenolic compound whose cytoprotective activity in culti-
vated neurons, for example, is unmatched by any other phenol,
thiol, polyene, or nitrone [4,5], we speculate that aromatic amines
may possess some inherent structural advantage with respect to
potential antioxidant activities, and we conclude that this advan-
tage is their better stabilization in the radicalized state when car-
rying two, potentially coupled, aromatic ring systems. This idea
is supported by the fact that simple aromatic amines (such as 4-
dodecylaniline) are just as potent as simple phenolic compounds
(such as 4-dodecylphenol), while both of these structures are
clearly less potent than diphenylamines [20]. Furthermore, the
compound NH-toc was primarily designed as to obtain a close size
and solubility match to its designated counterpart, tocopherol, and
may thus not be optimized as an antioxidant yet. For instance,
methylation or the addition of other substituents to the bare phe-
nothiazine head group explored in this study may well result in an
even better cytoprotective agent.
Beyond this merely biochemical consideration, it is clear that
potential receptor-dependent mechanisms of authentic a-tocoph-
erol or tocopherol’s in vivo ‘‘vitamin E activity’’ in animals will
not necessarily be mimicked by NH-toc, if just for the reason that
without a suitable transfer protein as existing for a-tocopherol
[29], NH-toc would probably exhibit a much less efﬁcient resorp-
tion. In addition, chromanol and phenothiazine possess differentdegradation and excretion pathways, which might likewise inﬂu-
ence their relative efﬁcacy in experimental animals. Nevertheless,
regarding their primary biochemical activity as lipid peroxidation
inhibitors and cytoprotective agents, aromatic amines (here, phe-
nothiazine) can in fact be much more potent than even reﬁned
phenols (here, chromanol). This raises the question why it was still
the chromanol-headed compound tocopherol that was selected as
nature’s primary chain-breaking antioxidant rather than an aro-
matic amine, especially in view of the fact that biosynthetic path-
ways do exist for both classes of compounds [30,31].
Tocopherol synthesis in plants starts with tyrosine and proceeds
via homogentisate, in which the later para-conﬁguration of the two
oxygen substituents of the aromatic ring is already preformed, to 2-
methyl-6-phytyl-1,4-benzoquinone, a highly lipophilic isopren-
ophenol [31]. Tocopherol synthesis is completed by a ring closure
reaction yielding d-tocopherol, with possible methylation reactions
resulting in b-, c- or a-tocopherol. Intriguingly, each of these syn-
thetic steps (lipophilization; ring closure; methylation) raises the
antioxidant capacity of the resulting product, as detailed in the fol-
lowing. Tyrosine, a primordial mono-phenolic compound and pro-
teinogenic amino acid, has been viewed as one of the oldest, if
not the oldest chain-breaking antioxidant [11,32]. Tyrosine vastly
gains antioxidant and cytoprotective activity when coupled with
a lipophilic tail [11]. The ring closure reaction to yield a chromanol
then enforces a molecular conformation in which the para-oxygen’s
lone pairs are speciﬁcally angled to further stabilize the radicalized
state of the molecule [1]. Lastly, methylation especially of the phe-
nolic ortho-positions lends additional inductive and steric stability
to the radicalized phenoxyl state [12].
716 M.J. Ohlow et al. / FEBS Letters 586 (2012) 711–716In view of this biosynthetic and evolutionary sequence of
events, it appears that when nature was forced to develop better
hydrogen-donating antioxidants due to rising ambient oxygen con-
centrations or other prooxidative changes in the environment, it
was more opportune to stick to the once chosen structural motif
and to gradually ameliorate the already available and approved
phenolic strategy of antioxidation, rather than to shift concepts
and to develop a totally new class of merely prospectively superior
structures. This interpretation corresponds with the coevolution
theory as pertaining to the origin of metabolic pathways [33].
The idea of coevolution is endorsed by the observation that the
biosynthesis of aromatic amines generally depends on the anthra-
nilate pathway, which is regarded to be a rather novel biosynthetic
avenue as it predominantly provides tryptophan [30], the most re-
cent of the standard proteinogenic amino acids [34]. Beyond tryp-
tophan, only very few other metabolites descending from
anthranilate have evolved, such as the acridone alkaloids [35].
Hence, it is quite possible that nature has just chosen phenols as
prevailing chain-breaking antioxidants because the anthranilate
pathway was not yet available when prooxidative changes in the
environment demanded the development of a specialized, high-
efﬁciency antioxidant, which tocopherol has become to be.
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